Wrap Text
Form 8-K Current Report
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, ASPI stockholders are advised
that a Form 8-K has been filed with the U.S. Securities and Exchange Commission.
On September 6, 2025, the Board of Directors (the "Board") of ASP Isotopes Inc. (the "Company"), effective
as of September 8, 2025, increased the size of the Board to seven (7) members and elected Ralph L.
Hunter to fill the vacancy on the Board resulting from such increase in the number of directors. Mr. Hunter
will serve as a Class II director of the Board, with a term expiring at the 2027 annual meeting of the
stockholders of the Company or until his earlier resignation or removal. Effective as of September 8, 2025,
Mr. Hunter was also designated as a member of the Board of Managers of Quantum Leap Energy LLC, a
wholly owned subsidiary of the Company.
There is no arrangement or understanding between Mr. Hunter and any other person, pursuant to which
he was selected as a director, and there is no family relationship between Mr. Hunter and any of the
Company's other directors or executive officers. The Company is not aware of any transaction involving
Mr. Hunter requiring disclosure under Item 404(a) of Regulation S-K. Additional information about Mr.
Hunter is set forth below.
Ralph L. Hunter, age 60, has over thirty five years of experience in the nuclear power generation
industry. Since June 2025, Mr. Hunter has been the Chairman and Chief Executive Officer of RC Nuclear
Consultants, LLC, a consulting company he established to help investors, technology companies, data
center developers, power off takers and others navigate the new nuclear landscape. From February 2024
to June 2025, Mr. Hunter was President and Chief Executive Officer of Orion Nuclear Energy Corporation
where he led the development company in securing opportunities nationally for both small modular reactors
and micro-reactors. From 2013 to February 2024, Mr. Hunter led the development of Constellation Energy
Corporation's international clean energy business in his role as President of Constellation Generation
Development, LLC (CGD), and was responsible for all of Constellation's (formerly Exelon Generation)
development activities in the nuclear sector worldwide. Mr. Hunter served as Chair on the U.S. Civil Nuclear
Trade Advisory Committee (CINTAC) which promoted civil nuclear energy exports, supported marketing
U.S. civilian nuclear technologies, innovative U.S. nuclear technologies and the capabilities of U.S. nuclear
operators and suppliers. Representing Constellation's investment in small modular nuclear reactors
internationally, Mr. Hunter also served on the Board of Rolls-Royce SMR Limited, a company involved in
the United Kingdom's clean energy development. Mr. Hunter holds both a Bachelor of Engineering degree
in Nuclear Engineering and a Master of Engineering degree in Nuclear Engineering from the University of
Florida. He also attended the Executive Management Program at the Darden School of Business at the
University of Virginia and is a certified Project Management Professional. The Board believes that Mr.
Hunter's extensive relevant experience and competencies, including senior management experience,
financial expertise, knowledge of the nuclear energy sector and risk governance, will be a valuable addition
to the Board.
Mr. Hunter will be entitled to compensation in accordance with the Company's non-employee director
compensation policy approved by the Board in October 2024 (attached as Exhibit 10.31 to the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with Securities and
Exchange Commission on March 31, 2025). In connection with his election to the Board, on September 8,
2025, Mr. Hunter received an award of 10,470 shares of restricted stock, which shall vest in full on the one-
year anniversary of the grant date (subject to continued service as a director) under the Company's 2022
Equity Incentive Plan. Mr. Hunter will be eligible for additional grants under the Company's non-employee
compensation policy beginning at the Company's 2025 annual meeting of stockholders.
Mr. Hunter has entered into the Company's standard form of indemnification agreement, a form of which
has been filed as Exhibit 10.4 to the Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 2024, filed with Securities and Exchange Commission on March 31, 2025.
A copy of the Form 8-K can also be found at: Inline Viewer: ASP Isotopes Inc. 8-K 2025-09-06
8 September 2025
Sponsor
Valeo Capital Proprietary Limited
Date: 08-09-2025 03:50:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
